Unit of Internal Medicine, "V. Cervello" Hospital, Ospedali Riuniti "Villa Sofia-Cervello", 90146 Palermo, Italy.
Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.
Nutrients. 2021 Oct 27;13(11):3833. doi: 10.3390/nu13113833.
Lactose intolerance is the most frequent food intolerance, but many subjects with self-reported milk intolerance (SRMI) are asymptomatic at lactose hydrogen breath test (LHBT). The aim of this study was to evaluate the frequency of lactose intolerance in SRMI patients and their clinical characteristics.
In a retrospective study, the clinical records of 314 SRMI patients (259 females, mean age: 39.1 ± 13.5 years) were reviewed; 102 patients with irritable bowel syndrome (IBS) served as controls. In a prospective study, 42 SRMI patients, negatives at the LHBT, underwent a double-blind, placebo-controlled (DBPC) whole cow's milk challenge.
In the retrospective study, only 178 patients (56%) were lactose maldigesters and intolerant at LHBT; 68% of the subjects with SRMI were suffering from IBS; 74% reported dyspepsia ( = 0.0001 vs. IBS controls); and weight loss was recorded in 62 SRMI patients (20%) ( = 0.01 vs. IBS controls). Duodenal histology showed intra-epithelial lymphocytosis in about 60% of cases. In the prospective study, 36 patients (86%) experienced symptoms during the DBPC cow's milk challenge, and only 4 patients (9%) reacted to placebo ( = 0.0001).
A percentage of SRMI patients were not suffering from lactose intolerance. DBPC revealed that SRMI patients had clinical reactions when exposed to whole cow's milk.
乳糖不耐受是最常见的食物不耐受,但许多自述对牛奶不耐受(SRMI)的患者在乳糖氢呼气试验(LHBT)中并无症状。本研究旨在评估 SRMI 患者中乳糖不耐受的发生率及其临床特征。
在一项回顾性研究中,回顾了 314 例 SRMI 患者(259 例女性,平均年龄:39.1 ± 13.5 岁)的临床记录;102 例肠易激综合征(IBS)患者作为对照。在一项前瞻性研究中,42 例 LHBT 阴性的 SRMI 患者接受了双盲、安慰剂对照(DBPC)全牛奶挑战。
在回顾性研究中,仅有 178 例患者(56%)为 LHBT 乳糖不良消化者且不耐受;68%的 SRMI 患者患有 IBS;74%的患者报告有消化不良(=0.0001 比 IBS 对照组);62 例 SRMI 患者(20%)出现体重减轻(=0.01 比 IBS 对照组)。十二指肠组织学显示约 60%的病例存在上皮内淋巴细胞增多。在前瞻性研究中,36 例患者(86%)在 DBPC 牛奶挑战期间出现症状,仅 4 例患者(9%)对安慰剂有反应(=0.0001)。
一部分 SRMI 患者并未患有乳糖不耐受。DBPC 显示 SRMI 患者在接触全牛奶时会出现临床反应。